Published in Prax Klin Pneumol on September 01, 1984
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (2000) 2.73
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Ann Oncol (2002) 2.14
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer (1993) 2.08
[Further cases of foot-and-mouth disease virus infections in man]. Zentralbl Bakteriol Orig (1965) 1.64
[Recommendations on the therapy of bronchial carcinoma]. Pneumologie (2002) 1.39
Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancer. J Clin Oncol (2001) 1.32
A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer. Ann Oncol (2011) 1.15
Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer. Br J Cancer (2008) 1.14
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma. Ann Oncol (2005) 1.14
Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study. J Clin Oncol (2001) 1.04
Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, pemetrexed disodium, ALIMTA) and cisplatin: a multicenter phase II trial. Ann Oncol (2000) 1.00
Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapy. Eur Respir J (2006) 0.99
Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients. J Clin Oncol (1998) 0.94
Substrate-induced redox change of selenium in glutathione peroxidase studied by x-ray photoelectron spectroscopy. Biochim Biophys Acta (1975) 0.94
Prognostic factors in patients with advanced non-small cell lung cancer: data from the phase III FLEX study. Lung Cancer (2012) 0.93
The plasma cholinesteerases: a new perspective. Adv Clin Chem (1981) 0.92
Pulmonary metastasizing hemangiopericytoma. Am J Clin Oncol (1988) 0.90
Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). Ann Oncol (1991) 0.88
Serum and sputum levels of cefaclor. Postgrad Med J (1979) 0.87
[Research on the ferments of human blood. XII. The role of an arylesterase fraction from the liver in human fat metabolism]. Hoppe Seylers Z Physiol Chem (1966) 0.86
Randomized study of vinorelbine--gemcitabine versus vinorelbine--carboplatin in patients with advanced non-small cell lung cancer. Lung Cancer (2005) 0.86
Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases. Lung (1994) 0.83
Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer. Semin Oncol (1997) 0.83
[Mediastinoscopy and bronchial cancer]. Bronches (1966) 0.82
[Recommendations on the diagnosis of bronchial carcinoma. German Pneumology Society]. Pneumologie (2000) 0.81
GLOB-1: a prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients. Ann Oncol (2002) 0.80
[Surgical intervention in the external area of the middle cranial fossa]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1969) 0.80
[Surgical problems in the diagnosis of tumors in the retromaxillary space]. Z Laryngol Rhinol Otol (1971) 0.80
[Functional rehabilitation of the pharynx in surgically treated neoplasms]. Z Laryngol Rhinol Otol (1971) 0.80
[Chemotherapy of advanced non-small-cell and small-cell bronchial carcinoma with bendamustine--a phase II study]. Pneumologie (1998) 0.80
[Retromaxillary space. Presentation from the clinical, x-ray and surgical viewpoint]. Aktuelle Otorhinolaryngol (1970) 0.79
Recombinant granulocyte colony stimulating factor in the treatment of small cell lung cancer: a long-term follow-up. Eur J Cancer (1995) 0.79
[Plastic surgery of the frontal bone defect with special reference to tantalum]. HNO (1973) 0.78
European School of Oncology. First Euro-American Forum on Lung Cancer Treatment. Eur J Cancer (1994) 0.78
[A phase II multicenter study of gemcitabine in non small cell lung cancers]. Bull Cancer (1997) 0.78
X-ray photoelectron spectroscopic properties of Hg-thionein. FEBS Lett (1974) 0.78
[Cisplatin, vindesine and VP 16-213 in the treatment of inoperable non-small cell bronchial carcinoma. A clinical phase II study]. Onkologie (1984) 0.78
Traceability in fluorometry: Part II. Spectral fluorescence standards. J Fluoresc (2005) 0.78
[Chemotherapy of malignant pleural mesothelioma: have we made any progress?]. Zentralbl Chir (2008) 0.78
Treatment of cancer weight loss in patients with advanced lung cancer. Oncology (1992) 0.77
The use of composite grafts for reconstruction of the trachea and subglottic airway. Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol (1977) 0.77
Traceability in fluorometry--Part I: Physical standards. J Fluoresc (2005) 0.77
An update on European randomized studies in non-small cell lung cancer. Semin Oncol (1998) 0.77
[Phase II-trial of tirapazamine in combination with cisplatin and gemcitabine in patients with advanced non-small-cell-lung-cancer (NSCLC)]. Pneumologie (2004) 0.77
[Ester-splitting enzymes of the human lung]. Hoppe Seylers Z Physiol Chem (1967) 0.77
Pirarubicin in advanced non-small cell lung cancer. A trial of the Phase I/II Study Group of the Association for Medical Oncology of the German Cancer Society. Onkologie (1990) 0.76
[Hypoglossal-facial nerve cross-over for rehabilitation of the paralyzed face (author's transl)]. Laryngol Rhinol Otol (Stuttg) (1981) 0.76
[Plastic correction of defects in the forehead and orbital area]. Asthet Med (Berl) (1968) 0.75
CT findings of aspergillosis in the paranasal sinuses. Arch Otorhinolaryngol (1987) 0.75
Gemcitabine plus etoposide in chemonaive extensive disease small-cell lung cancer: a multi-centre phase II study. Ann Oncol (2001) 0.75
[Reconstruction of the anterior wall of the auditory canal after removal of a widespread giant cell tumor]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1967) 0.75
[What is the advantage of the lateral approach to the pterygopalatine fossa, infratemporal fossa and the orbit?]. Arch Otorhinolaryngol (1974) 0.75
[Clinical aspects and therapy of mesenchymal tumors of pharynx and tonsils]. Fortschr Kiefer Gesichtschir (1970) 0.75
[Does dental care influence the progression of caries in children and adolescents?]. Stomatol DDR (1978) 0.75
[Pulmonary sequestration (author's transl)]. Monatsschr Kinderheilkd (1982) 0.75
[Tissue substitution by means of lyophilised dura in thoracic surgery]. Langenbecks Arch Chir (1970) 0.75
Models for metal-sulfur coordination in copper proteins. J Inorg Biochem (1979) 0.75
[Fluorescence microscopic studies on the beginning of the mineralization of rat incisors]. Stomatol DDR (1979) 0.75
[Bronchial carcinoma and paraneoplastic neuromyopathy]. Fortschr Med (1977) 0.75
[Partial lung resection for peripheral bronchial carcinoma]. Pneumonologie (1971) 0.75
[On the effect of the ear plug of the hearing aid on the frequency range of sound transmission from the receiving part to the tympanic membrane. (Experiments with models on an artificial ear)]. Acta Otolaryngol (1966) 0.75
[Rapid diagnosis of carbon monoxide poisoning and quantitative determination of CO-Hb in blood]. Int J Environ Anal Chem (1979) 0.75
[Permanent lesions following pleural diseases]. Prax Pneumol (1972) 0.75
Infections after pleuro-pulmonary surgery. Thorac Cardiovasc Surg (1983) 0.75
[Adhesive sealing of fissures and pits for the prevention of caries. Review]. Stomatol DDR (1975) 0.75
[Diagnosis and treatment of salivary gland diseases]. Zahnarztl Prax (1969) 0.75
[Residual lesions after chest injuries; suggestions for their treatment (author's transl)]. Prax Klin Pneumol (1977) 0.75
[Vacuolisation of odontoblasts and regressive metamorphoses from viewpoint of pulp-dentin system function]. Zahn Mund Kieferheilkd Zentralbl (1975) 0.75
[Studies of the permeability of human dentin Part I: Basic studies of constant physiological parameters and experimental variables (author's transl)]. Zahn Mund Kieferheilkd Zentralbl (1978) 0.75
[Haematothorax during the course of pulmonary, pleural or mediastinal diseases (author's transl)]. Langenbecks Arch Chir (1974) 0.75
[Pulmonary abscess]. Chirurg (1980) 0.75
[Perfusion scintigraphic studies of the lung in bronchiectasis]. Pneumonologie (1970) 0.75
[Pleural empyema]. Chirurg (1980) 0.75
[Work profile of social work in inpatient psychotherapy. Clinical fields and social rights implications]. Psychiatr Prax (2000) 0.75
[Changes in microhardness of hard dental tissues of rabbits after internal medication of antibiotics (author's transl)]. Zahn Mund Kieferheilkd Zentralbl (1979) 0.75
[Otorhinolaryngologic experiences with cryogenic surgery]. Dtsch Med Wochenschr (1966) 0.75
[Gastro-duodenal ulcer and bronchial carcinoma]. Med Welt (1977) 0.75
[On the acid solubility of the dental enamel of rabbits after internal administration of various antibiotic substances (author's transl)]. Zahn Mund Kieferheilkd Zentralbl (1979) 0.75
[The thoracic surgical treatment of tracheal stenoses (author's transl)]. HNO (1980) 0.75
[Studies on the fluorescent intensity of various tetracycline preparations in the dentin of the gnawing teeth of rats (author's transl)]. Zahn Mund Kieferheilkd Zentralbl (1979) 0.75
[Bronchoplastic operations: endoscopic aspects]. Thoraxchir Vask Chir (1972) 0.75
[The significance of the nasal septum for the traumatically damaged nose]. Fortschr Kiefer Gesichtschir (1967) 0.75
[Functional interpretation of lung scintigraphic findings]. Beitr Klin Erforsch Tuberk Lungenkr (1969) 0.75
[Surgery of buccal carcinomas]. Fortschr Kiefer Gesichtschir (1968) 0.75
[The effect of dimethyl sulfoxide (DMSO) on the blood circulation in the pulp]. Zahn Mund Kieferheilkd Zentralbl (1975) 0.75
[Mismanagement of chest trauma; sequels and the possibility of repair (author's transl)]. Prax Klin Pneumol (1979) 0.75
[The free skin graft and its use in surgical management of oral cavity tumors]. Z Laryngol Rhinol Otol (1968) 0.75
[Swallowing following mouth and pharyngeal surgery]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1971) 0.75
GaBi alloy liquid metal ion source for microelectronics research. Ultramicroscopy (2007) 0.75
[Postoperative development of function following lung resection: early phase]. Pneumonologie (1972) 0.75
[Complications following mediastinoscopy. Prevention and therapy]. Fortschr Med (1979) 0.75
[Studies on the problem of a composite anchoring post and core]. Stomatol DDR (1977) 0.75
[Surgery of retromaxillary space]. Monatsschr Ohrenheilkd Laryngorhinol (1971) 0.75
[On benign tumors located near the base of the skull]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1968) 0.75
[The therapeutic value of pulpotomy; conditions, possibilities, limitations]. Stomatol DDR (1976) 0.75
[Efficiency criteria and priorities in school age pedodontic care]. Stomatol DDR (1979) 0.75
Liquid metal alloy ion source based metal ion injection into a room-temperature electron beam ion source. Rev Sci Instrum (2012) 0.75
[Cicatricial cancer of the lung]. Dtsch Med Wochenschr (1965) 0.75